A

Alkeus Pharmaceuticals

Develops ALK-001 therapy for Stargardt

Manager 2 - Clinical Studies

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$120k - $168k

About the Job

Requirements

  • A bachelor's degree in a scientific, healthcare, nursing, pharmacy, or related discipline is required.
  • At least 7 years of clinical research or clinical operations experience in biotechnology, pharmaceutical, CRO, or related environments is required.
  • Demonstrated experience supporting Phase I–III clinical studies is required.
  • Strong experience overseeing CROs and vendors is required.
  • Experience managing clinical studies from start-up and site management through enrollment strategies, database lock, and closeout is required.
  • Experience managing study budgets and vendor contracts is required.
  • Prior experience supporting regulatory inspections and audit readiness is required.
  • The role requires the ability to travel up to 20% of the time, as needed.
  • The role requires verbal and written communication skills, including translating complex concepts for different audiences.
  • The role requires the ability to lead fast-paced projects and provide hands-on expertise.

Responsibilities

  • Lead end-to-end operational planning, implementation, and execution of assigned clinical studies from feasibility and start-up through database lock, closeout, and archival.
  • Support the development and maintenance of integrated study timelines, study management plans, operational strategies, risk assessments, decision logs, and study metrics.
  • Drive study milestones and deliverables, including site activation, enrollment, data collection, monitoring, database lock, and study closeout.
  • Monitor study performance and proactively identify risks related to timelines, enrollment, budget, quality, data, vendors, sites, and resources.
  • Develop and implement mitigation and contingency plans for study risks and operational challenges.
  • Lead resolution of complex study issues and escalate significant risks or decisions to Clinical Operations leadership and appropriate governance forums.
  • Provide regular study status, risk, budget, and milestone updates to program and functional leadership.
  • Provide operational oversight of CROs, central laboratories, imaging vendors, technology providers, and other external service providers supporting assigned studies.
  • Participate in CRO and vendor identification, evaluation, selection, contracting, and study start-up activities.
  • Monitor CRO and vendor performance against contractual obligations, timelines, budgets, quality requirements, deliverables, and key performance indicators.
  • Review study plans, metrics, monitoring reports, study documentation, invoices, forecasts, and change orders as appropriate.
  • Escalate significant vendor performance concerns and oversee corrective and preventive actions through resolution.
  • Provide leadership and oversight for site identification, qualification, selection, activation, enrollment, retention, monitoring, and closeout.
  • Monitor site performance, enrollment, protocol compliance, data quality, and other key study metrics.
  • Oversee site qualification, initiation, interim monitoring, and closeout activities.
  • Review monitoring reports and trends to identify systemic issues, risks, or areas requiring intervention.
  • Conduct or support co-monitoring and other oversight activities, as needed, to assess study quality and monitoring effectiveness.
  • Maintain effective relationships with investigative sites and facilitate resolution of operational, recruitment, and protocol-related issues.
  • Provide leadership and escalation support to CRAs and study team members regarding site management and monitoring issues.
  • Ensure clinical studies comply with ICH-GCP, applicable FDA, EMA, and local regulatory requirements, company SOPs, approved study plans, and protocols.
  • Support internal audits, CRO/vendor audits, investigator-site audits, and regulatory inspections.
  • Ensure protocol deviations, quality issues, and significant operational risks are documented, assessed, escalated, and resolved.
  • Partner with Quality Assurance and other functions to oversee CAPAs and other corrective actions, as applicable.
  • Identify documentation gaps and ensure corrective actions are implemented and tracked to completion.
  • Support review of study budgets, forecasts, accruals, and financial plans in partnership with Clinical Operations leadership and Finance, as delegated.
  • Monitor study expenditures and vendor invoices against approved budgets and contracted scope.
  • Identify opportunities to manage study costs while maintaining quality and timeline requirements.
  • Contribute to the development and continuous improvement of Clinical Operations processes, SOPs, templates, tools, and best practices.
  • Capture and implement lessons learned across studies.
  • Support departmental initiatives and other Clinical Operations projects as assigned.
  • Deliver other related projects as assigned.

Desired Qualifications

  • An advanced degree (MS, PhD, or PharmD) is a plus.
  • Experience in rare disease and ophthalmology is preferred.

About the Company

Alkeus Pharmaceuticals

Develops ALK-001 therapy for Stargardt

Alkeus Pharmaceuticals develops therapies for genetic eye diseases, with ALK-001 as its lead candidate for Stargardt disease. Stargardt is caused by ABCA4 gene defects, leading to toxic by-products that damage vision. ALK-001 is a modified form of vitamin A that preserves the necessary functions of vitamin A for sight but reduces formation of harmful by-products, addressing a condition with no approved treatments for many patients in the US. The product works by altering vitamin A chemistry to prevent toxic buildup while supporting normal visual processes. The company earns by researching, patenting, and eventually selling its therapies to healthcare providers and patients. Its focus on Stargardt disease positions it in a niche genetic-eye-disease market with potential applicability to other retinal disorders, offering a path to a scalable therapy through drug development and IP protection.

Company size
51-200
Company stage
Acquired
Total funding
$150.1M
Headquarters
Boston, MA
Founded
2011

Recently Posted Jobs

Explore more opportunities at Alkeus Pharmaceuticals

See more jobs